Clinical Trials · NCT06184633
DUTCH Weight Control in Atrial Fibrillation Study
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- Rijnstate Hospital
- Enrollment
- 280
- Start date
- Jul 2024
- Locations
- 20 sites, Netherlands
- Primary endpoint
- The primary efficacy clinical endpoint of the trial is assessed at 12 months by a 7 point scale. Only the worst clinical outcome will be retained as the primary efficacy outcome